DACH1: Its role as a classifier of long term good prognosis in luminal breast cancer

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Powe, Desmond G ^a,b   Dhondalay, Gopal Krishna R ^a   Lemetre, Christophe ^c   Allen, Tony ^a   Habashy, Hany O ^d   Ellis, Ian O ^b   Rees, Robert ^a   Ball, Graham R ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); PATIENT OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; RECEPTORS, ESTROGEN; RISK FACTORS; TRANSCRIPTION FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84894251319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084428     Document Type: Article

References (44)

1. Cancer Research UK website. Available: http://publications. cancerresearchuk.org/downloads/Product/CS-KF-BREAST.pdf. Accessed 2012 Mar 21.
2. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
3. Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast cancr. Nature 406: 747-752.
4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874. (Pubitemid 32878711)
5. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418-8423. (Pubitemid 36842560)
6. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, et al. (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100: 10393-10398. (Pubitemid 37071889)
7. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312. (Pubitemid 350232263)
8. Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, et al. (2004) Discovery of estrogen receptor a target genes and response elements in breast tumor cells. Genome Biology5.
9. Kim HJ, Cui X, Hilsenbeck SG, Lee AV (2006) Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer. Clin Cancer Res 12: 1013s-1018s. (Pubitemid 43259837)
10. Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, et al. (2010) Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat.
11. Gasparri F, Wang N, Skog S, Galvani A, Eriksson S (2009) Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan(TM) assays. European Journal of Cell Biology 88: 779-785.
12. Habashy HO, Rakha EA, Ellis IO, Powe DG (2013) The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer. Breast Cancer Res Treat 140: 307-316.
13. Habashy HO, Powe DG, Rakha EA, Ball G, Macmillan RD, et al. (2010) The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Res Treat 120: 603-612.
14. Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, et al. (2009) The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res 69: 5752-5760.
15. Cruz JA, Wishart DS (2006) Applications of Machine Learning in Cancer Prediction and Prognosis. Cancer Informatics 2: 59-77. (Pubitemid 43854386)
16. McCulloch W, Pitts W (1943) A logical calculus of the ideas immanent in nervous activity. Bulletin of Mathematical Biology 5: 115-133.
17. Lancashire LJ, Roberts DL, Dive C, Renehan AG (2011) The development of composite circulating biomarker models for use in anticancer drug clinical development. Int J Cancer 128: 1843-1851.
18. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, et al. (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature Medicine 7: 673-679. (Pubitemid 32588022)
19. Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, et al. (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116: 340-350. (Pubitemid 40993329)
20. Lisboa PJ, Taktak AF (2006) The use of artificial neural networks in decision support in cancer: a systematic review. Neural Netw 19: 408-415. (Pubitemid 44183627)
21. Lancashire LJ, Rees RC, Ball GR (2008) Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach. Artif Intell Med 43: 99-111.
22. Dhondalay GK, Tong DL, Ball GR (2011) Estrogen receptor status prediction for breast cancer using artificial neural network; 2011 10-13 July 2011. pp. 727-731.
23. Heanue TA, Davis RJ, Rowitch DH, Kispert A, McMahon AP, et al. (2002) Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes. Mechanisms of Development 111: 75-87. (Pubitemid 34136980)
24. Mardon G, Solomon NM, Rubin GM (1994) Dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 120: 3473-3486. (Pubitemid 24366992)
25. Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, et al. (2009) The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Research 59: 3347-3355.
26. Wu K, Li A, Rao M, Liu M, Dailey V, et al. (2006) DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 26: 7116-7129. (Pubitemid 44479729)
27. Wu K, Jiao X, Li Z, Katiyar S, Casimiro MC, et al. (2011) Cell fate determination factor Dachshund reprograms breast cancer stem cell function. J Biol Chem 286: 2132-2142.
28. Wu K, Katiyar S, Li A, Liu M, Ju X, et al. (2008) Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proc Natl Acad Sci U S A 105: 6924-6929. (Pubitemid 351754506)
29. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161. (Pubitemid 44359727)
30. ArrayExpress website. Available: http://www.ebi.ac.uk/arrayexpress/. Accessed 2012 Mar 21.
31. Lemetre C, Lancashire L, Rees R, Ball G (2009) Artificial Neural Network Based Algorithm for Biomolecular Interactions Modeling. In: Cabestany J, Sandoval F, Prieto A, Corchado J, editors. Bio-Inspired Systems: Computational and Ambient Intelligence: Springer Berlin Heidelberg. pp. 877-885.
32. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2002) Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research 12: 2498-2504. (Pubitemid 37428274)
33. Habashy HO, Powe DG, Rakha EA, Ball G, Paish C, et al. (2008) Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. Eur J Cancer 44: 1541-1551.
34. McCarty KS, Jr., Miller LS, Cox EB, Konrath J, McCarty KS, Sr. (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Archives of Pathology and Laboratory Medicine 109: 716-721. (Pubitemid 16237466)
35. Watanabe A, Ogiwara H, Ehata S, Mukasa A, Ishikawa S, et al. (2011) Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells. PNAS 108: 12384-12389.
36. Nan F, Lu Q, Zhou J, Chen L, Popov VM, et al. (2009) Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biology and therapy 8: 1534-1539.
37. Liang F, Lu Q, Sun S, Zhou J, Popov VM, et al. (2012) Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome. Interanational Journal of Gynecolopgical Cancer 22: 386-393.
38. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, et al. (2003) DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 278: 51673-51684. (Pubitemid 38020413)
39. DeAngelis T, Wu K, Pestell R, Baserga R (2011) The type 1 insulin-like growth factor receptor and resistance to DACH1. Cell Cycle 10: 1956-1959.
40. Ward S, Scope A, Rafia R, Pandor A, Harman S, et al. (2012) Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management.
41. Lancashire LJ, Powe DG, Reis JS, Rakha E, Lemetre C, et al. (2010) A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast Cancer Res Treat 120: 83-93.
42. Hoch RV, Thompson DA, Baker RJ, Weigel RJ (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. International Journal of Cancer 84: 122-128. (Pubitemid 29133821)
43. Fang SH, Chen Y, Weigel RJ (2009) GATA-3 as a marker of hormone response in breast cancer. J Surg Res 157: 290-295.
44. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, et al. (2001) Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast. American Journal of Pathology 158: 1011-1019. (Pubitemid 32221793)